ASTI.CN Aquarius Surgical (CNQ) 23 Jan 2026: down 33% key drivers
ASTI.CN stock fell 33.33% in market hours on 23 Jan 2026, closing at C$0.01 on the CNQ exchange. The move follows thin trading with volume 1,000 versus an average volume of 5,624, and a prior close of C$0.015. Investors cited weak financial metrics, negative EPS of -0.02, and low liquidity as immediate pressure points. We review valuation, technicals, sector context, and Meyka AI model forecasts to explain the top loser status and what investors should watch next.
Why ASTI.CN stock fell today
The main driver was low liquidity and a sharp intraday selloff that pushed the price to C$0.01, down C$0.005 from the previous close. Trading volume of 1,000 shares was only 0.18 times average volume, amplifying price moves. Negative fundamentals such as EPS -0.02 and a negative PE ratio of -0.50 increased downside sensitivity. Short-term technicals and limited news flow left holders to mark positions lower during market hours.
ASTI.CN stock financial snapshot and valuation
Aquarius Surgical Technologies Inc. (ASTI.CN) shows a market cap of C$275,992 and 27,599,200 shares outstanding. Price averages are C$0.01 (50-day 0.01) and C$0.01 (200-day 0.01), with a year high of C$0.03 and year low C$0.01. Key ratios include price-to-sales 3.27, EV/Sales 81.14, and book value per share -0.18. The company’s current ratio is 0.05, flagging short-term liquidity stress and elevated operational risk.
Technical picture and liquidity for ASTI.CN stock
Technical indicators show muted momentum: RSI 45.72, ADX 11.17 indicating no trend, and OBV -10,950 reflecting net outflows. The 50-day average price is C$0.01 and relative volume is 0.18, so price moves are easily exaggerated. Low ATR and flat Bollinger bands at C$0.01 underline very low intraday volatility but high relative risk when trades occur.
Meyka AI grade and price forecast for ASTI.CN stock
Meyka AI rates ASTI.CN with a score out of 100: 59.86 / Grade C+ — HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Company-level ratings from other models show C- / Strong Sell dated 2026-01-22, highlighting disagreement among signals. Meyka AI’s forecast model projects a 12-month target of C$0.02, versus the current C$0.01, implying an upside of 100.00%; forecasts are model-based projections and not guarantees.
Sector and competitor context for ASTI.CN stock
ASTI.CN operates in Healthcare — Medical Devices, a sector with mixed short-term performance and average price-to-book near 1.46. Aquarius Surgical’s negative PB and weak liquidity place it well below sector norms. For relative context and recent comparisons, see competitor pages on Investing.com source and MedMira comparisons source.
Risk factors and short-term outlook for ASTI.CN stock
Key risks include very low liquidity, negative operating cash flow per share -0.01, high enterprise value relative to sales, and a current ratio of 0.05. Near-term scenarios: downside test to C$0.005 if sellers persist, base case near the market price C$0.01, and a model-driven upside target C$0.02 in 12 months. Investors should monitor volume, any corporate updates, and sector moves for a trading signal.
Final Thoughts
ASTI.CN stock’s 33.33% decline to C$0.01 on 23 Jan 2026 reflects thin liquidity, negative EPS, and stretched valuation metrics relative to company size. Meyka AI rates ASTI.CN with a score of 59.86 (Grade C+, suggestion HOLD) while other signals flagged a C- / Strong Sell on 22 Jan 2026. Meyka AI’s forecast model projects a 12-month target of C$0.02, implying 100.00% upside from the current price, but that projection assumes improved liquidity and clearer revenue traction. Short-term risk remains high given a current ratio 0.05, negative operating cash flow, and enterprise value to sales at 81.14. Practical price scenarios: downside C$0.005, base C$0.01, and upside C$0.02. These figures are model-based and not guarantees. Use volume and any corporate announcements as gating criteria before position sizing. For live market tracking, consult Meyka AI’s real-time tools and the company page for updates.
FAQs
Why did ASTI.CN stock drop 33% on 23 Jan 2026?
ASTI.CN stock fell mainly due to very low liquidity, a modest sell wave, and weak fundamentals. Volume was 1,000 versus average 5,624, EPS is -0.02, and the current ratio is 0.05, amplifying downward moves during market hours.
What is Meyka AI’s forecast for ASTI.CN stock?
Meyka AI’s forecast model projects C$0.02 in 12 months versus the current C$0.01, implying an upside of 100.00%. Forecasts are model-based projections and not guarantees.
Is ASTI.CN stock a buy, hold, or sell now?
Meyka AI assigns ASTI.CN a C+ (59.86) grade with a HOLD suggestion. Other models list a C- / Strong Sell. Given liquidity and cash flow risks, many analysts would treat new positions as speculative.
What are the main risks for ASTI.CN stock short term?
Primary short-term risks are low liquidity, negative operating cash flow per share -0.01, tight current assets, and volatile micro-cap trading. These factors can cause outsized intraday moves during market hours.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
